⌘K

Login Start Free

Home/Filings/4/0001144204-19-029899

4//SEC Filing

Lu Lucy 4

Accession 0001144204-19-029899

CIK 0001644963other

View on SEC.gov Company Profile

Filed

Jun 4, 8:00 PM ET

Accepted

Jun 5, 4:41 PM ET

Size

5.5 KB

Accession

0001144204-19-029899

Insider Transaction Report

Form 4

Period: 2019-06-03

AVENUE THERAPEUTICS, INC.ATXI

DirectorPresident, CEO

Transactions

Award
Restricted Stock Units
2019-06-03+135,617→ 135,617 total
Exercise: $0.00Exp: 2024-06-03→ Common Stock (135,617 underlying)

Footnotes (1)

[F1]Each RSU represents the right to receive one share of common stock of Avenue Therapeutics, Inc. The RSUs vest upon the earliest to occur of the following: (i) Grantee's death or disability; (ii) a change in control of Avenue Therapeutics, Inc.; or (iii) the Second Stage Closing with InvaGen.

Documents

1 file

4
tv523097_form4.xmlPrimary
FORM 4

Issuer

AVENUE THERAPEUTICS, INC.

CIK 0001644963

Entity typeother

Related Parties

1

filerCIK 0001542419

Filing Metadata

Form type: 4
Filed: Jun 4, 8:00 PM ET
Accepted: Jun 5, 4:41 PM ET
Size: 5.5 KB

View on SEC.gov